D. Blackman

发表

The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk

David M Meads, Sven Plein, John P Greenwood, 2013, Heart.

Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.

A. D. Cunningham, H. Gray, C. Young, 2011, Journal of the American College of Cardiology.

Long-Term Durability of Transcatheter Aortic Valve Prostheses.

S. Anderson, P. Ludman, A. Myat, 2019, Journal of the American College of Cardiology.

Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.

Jeroen J. Bax, B. Prendergast, C. Hengstenberg, 2017, Journal of the American College of Cardiology.

Cardiovascular magnetic resonance assessment of 1st generation CoreValve and 2nd generation Lotus valves

S. Plein, J. Greenwood, D. Blackman, 2018, Journal of interventional cardiology.

Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).

J. Harnek, G. Rioufol, I. Meredith, 2017, The American journal of cardiology.

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort.

J. Harnek, G. Rioufol, I. Meredith, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients.

J. Harnek, G. Rioufol, T. Feldman, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience.

S. Redwood, D. Hildick-Smith, J. Kovac, 2016, JACC. Cardiovascular interventions.

Device-dependent association between paravalvar aortic regurgitation and outcome after TAVI

N. Moat, P. Ludman, D. Hildick-Smith, 2014, Heart.

Comparison of Direct Aortic and Subclavian Transcatheter Aortic Valve Implantation: recent knowledge/an update from the UK Transcatheter Aortic Valve Implantation (TAVI) registry in 2013-2015

A. Zaman, S. Redwood, P. Ludman, 2021 .

Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis.

B. Prendergast, L. Sharples, A. Baumbach, 2020, International journal of cardiology.

Lotus-in-Evolut R transcatheter aortic valve implantation for severe paravalvular leak.

D. Blackman, C. Malkin, S. Rashid, 2016, Journal of cardiology cases.

A review of the technical challenges and optimal valve choices in different clinical and anatomic scenarios

N. Ali, D. Blackman, 2019 .

Permanent Pacemaker Insertion After CoreValve Transcatheter Aortic Valve Implantation: Incidence and Contributing Factors (the UK CoreValve Collaborative)

A. Cook, R. Rajani, A. Baumbach, 2011, Circulation.

Impact of latest generation cardiac interventional X-ray equipment on patient image quality and radiation dose for trans-catheter aortic valve implantations.

Amber J. Gislason-Lee, S. Kengyelics, A. Davies, 2016, The British journal of radiology.

Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure.

M. Frenneaux, J. Morris-Thurgood, M. Schmitt, 2003, Clinical science.

The impact of transcatheter aortic valve implantation on quality of life: A mixed methods study

D. Blackman, F. Astin, J. Stephenson, 2017, Heart & lung : the journal of critical care.

Management of ST-elevation myocardial infarction

D. Blackman, R. Shelton, V. Gatenby, 2010 .

Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications.

J. Cockcroft, M. Frenneaux, M. Schmitt, 2002, British journal of clinical pharmacology.

The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percut

K. Abrams, J. Greenwood, V. Kunadian, 2016 .

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial

K. Abrams, J. Greenwood, V. Kunadian, 2014, Trials.

Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device.

F. Burzotta, C. Trani, G. Niccoli, 2004, International journal of cardiology.

Pre-procedural pacing bias among transcatheter aortic valves with higher post-procedure pacing rates: evidence from the UK TAVI Registry

S. Redwood, P. Ludman, D. Hildick-Smith, 2020, Heart and Vessels.

Consequence of Cerebral Embolism After Transcatheter Aortic Valve Implantation Compared With Contemporary Surgical Aortic Valve Replacement: Effect on Health-Related Quality of Life

M. Motwani, S. Plein, Bernhard Herzog, 2015, Circulation. Cardiovascular interventions.

Percutaneous coronary intervention in the UK: recommendations for good practice 2015

A. Baumbach, N. Curzen, S. Redwood, 2015, Heart.

Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease

H. Swanton, Duolao Wang, M. Flather, 2015, Journal of the American College of Cardiology.

Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study

H. Swanton, M. Flather, M. Dalby, 2016, Journal of Cardiovascular Magnetic Resonance.

Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.

S. Redwood, D. Hildick-Smith, J. Kovac, 2017, JACC. Cardiovascular interventions.

Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study.

R. Lange, R. Bauernschmitt, P. Leprince, 2014, European heart journal.

Acute Onset Hypotension

D. Blackman, V. Kushwaha, 2016 .

Clinical outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction according to sex and race

J. Greenwood, P. Baxter, D. Blackman, 2019, European heart journal. Acute cardiovascular care.

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention

J. Greenwood, P. Baxter, D. Blackman, 2019, Open Heart.

Complete Versus Lesion-Only Primary PCI

H. Swanton, M. Flather, M. Dalby, 2015, Journal of the American College of Cardiology.

Transcatheter Aortic Valve Implantation in the United KingdomCLINICAL PERSPECTIVE

H. Gray, C. Young, W. Banya, 2015 .

Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction

A. Baumbach, D. Blackman, M. Schwenkglenks, 2012, Heart.

Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention.

Christopher T. Chan, V. Džavík, R. Pinto, 2006, American heart journal.

Day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes

D. Blackman, A. Beswick, A. Banning, 2002, Heart.

Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.

R. Stables, D. Perera, S. Redwood, 2010, JAMA.

The impact of trans-catheter aortic valve replacement induced left-bundle branch block on cardiac reverse remodeling

S. Plein, J. Greenwood, T. Fairbairn, 2017, Journal of Cardiovascular Magnetic Resonance.

Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement.

Randolph P. Martin, M. Mack, D. Adams, 2019, JACC. Cardiovascular interventions.

Primary percutaneous coronary intervention for acute ST elevation myocardial infarction--first year's experience of a tertiary referral centre in the UK.

J. Greenwood, D. Blackman, J. Mclenachan, 2008, Clinical medicine.

Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience.

N. Ali, G. Nickenig, T. Pilgrim, 2020, JACC. Cardiovascular interventions.

Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.

J. Greenwood, D. Blackman, S. Wheatcroft, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantation.

N. Moat, P. Ludman, M. de Belder, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach.

A. Baumbach, D. Hildick-Smith, D. Blackman, 2011, Journal of the American College of Cardiology.

General anaesthesia in a patient with Brugada syndrome.

D. Blackman, K. Gupta, C. Edge, 2002, British journal of anaesthesia.

Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure

Andrew S. Holmes, S. Jackson, M. Lewis, 2004, European journal of heart failure.

Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction.

M. Frenneaux, J. Morris-Thurgood, M. Schmitt, 2001, Journal of the American College of Cardiology.

Survival relative to pacemaker status after transcatheter aortic valve implantation

B. Prendergast, A. Baumbach, A. Zaman, 2021, Catheterization and cardiovascular interventions.

Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement.

D. Blackman, E. A. Hudson, D. O'Regan, 2013, Interactive cardiovascular and thoracic surgery.

Complications of transcatheter aortic valve implantation: avoidance and management.

B. Prendergast, A. Baumbach, N. Moat, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Kingdom Transcatheter Aortic Valve Implantation) Registry High-Risk Patients With Severe Aortic Stenosis: The U.K. TAVI (United Long-Term Outcomes After Transcatheter Aortic Valve Implantation in

H. Gray, C. Young, S. Davies, 2011 .

Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012.

H. Gray, C. Young, W. Banya, 2015, Circulation.

Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry.

N. Moat, C. Gale, P. Baxter, 2014, Journal of interventional cardiology.

Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.

A. D. Cunningham, H. Gray, C. Young, 2011, Journal of the American College of Cardiology.

In‐hospital stroke after transcatheter aortic valve implantation: A UK observational cohort analysis

B. Prendergast, A. Baumbach, N. Curzen, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.

M. Dalby, S. Davies, N. Moat, 2017, JACC. Cardiovascular interventions.

Assessment of aortic stiffness by cardiovascular magnetic resonance following the treatment of severe aortic stenosis by TAVI and surgical AVR

M. Motwani, S. Plein, S. Sourbron, 2016, Journal of Cardiovascular Magnetic Resonance.

The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk

S. Plein, J. Greenwood, C. Hulme, 2013, Heart.

Influence of gender on clinical outcomes following transcatheter aortic valve implantation from the UK transcatheter aortic valve implantation registry and the National Institute for Cardiovascular Outcomes Research.

C. Bicknell, J. Mayet, N. Moat, 2014, The American journal of cardiology.

Multiple cerebral emboli following dislocation and retraction of a partially deployed CoreValve prosthesis during transcatheter aortic valve implantation

J. Greenwood, T. Fairbairn, D. Blackman, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

THE COMPLETE VERSUS LESION ONLY PRIMARY PCI TRIAL-CARDIOVASCULAR MRI SUBSTUDY (CVLPRIT-CMR)

H. Swanton, M. Flather, M. Dalby, 2015 .

Prosthetic valve endocarditis following transcatheter aortic valve implantation

N. Ali, D. Blackman, J. Sandoe, 2020, Journal of cardiovascular medicine.

TCT-733 Predictors of Permanent Pacemaker Implantation in Patients Treated in Routine Clinical Practice with the Repositionable and Fully Retrievable Lotus Valve.

V. Falk, P. Wenaweser, H. Ince, 2016, Journal of the American College of Cardiology.

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

Jeroen J. Bax, B. Prendergast, A. Unbehaun, 2018, European heart journal.

Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI)

C. Hengstenberg, J. Mehilli, T. Walther, 2018, European heart journal.

Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry.

A. D. Cunningham, N. Moat, C. Gale, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial

J. Moon, J. Greenwood, A. Sirker, 2019, American heart journal.

Extended Statement by the British Cardiovascular Intervention Society President Regarding Transcatheter Aortic Valve Implantation

N. Curzen, P. Ludman, D. Hildick-Smith, 2021, Interventional cardiology.

Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access

A. Zaman, J. Kovac, D. Blackman, 2020 .

A cohort study examining urgent and emergency treatment for decompensated severe aortic stenosis

N. Ali, D. Blackman, Arka Das, 2020, Journal of cardiovascular medicine.

Acute Reverse Remodelling After Transcatheter Aortic Valve Implantation: A Link Between Myocardial Fibrosis and Left Ventricular Mass Regression.

S. Plein, J. Greenwood, T. Fairbairn, 2016, The Canadian journal of cardiology.

Right ventricular function following surgical aortic valve replacement and transcatheter aortic valve implantation: A cardiovascular MR study.

S. Plein, J. Greenwood, G. McCann, 2016, International journal of cardiology.

What is the incidence of myocardial necrosis in elective patients discharged on the same day following percutaneous coronary intervention?

G. Niccoli, I. Porto, K. Channon, 2004, Heart.

Three-year clinical outcome with the Endeavor™ zotarolimus-eluting stent in primary percutaneous coronary intervention for ST elevation myocardial infarction: the Endeavor™ primary PCI study (E-PPCI).

J. Greenwood, D. Blackman, S. Wheatcroft, 2011, Journal of interventional cardiology.

Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts.

I. Porto, K. Channon, V. Džavík, 2007, The American journal of cardiology.

Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.

V. Falk, J. Wöhrle, D. Hildick-Smith, 2018, JACC. Cardiovascular interventions.

Quantitative Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement With Videodensitometry in a Large, Real-World Study Population: Subanalysis of RESPOND and Echocardiogram Association.

P. Serruys, R. Modolo, Chun-Chin Chang, 2019, JACC. Cardiovascular interventions.

Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.

K. Channon, R. Choudhury, D. Blackman, 2005, The Journal of invasive cardiology.

What Would Be the Ideal Drug-eluting Stent for Managing Patients with Long Lesions?

D. Blackman, R. Shelton, 2009 .

Insights on Embolic Protection, Repositioning, and Stroke: A Subanalysis of the RESPOND Study

V. Falk, I. Meredith, J. Wöhrle, 2020, Journal of interventional cardiology.

Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trials

J. Greenwood, D. Blackman, H. Bulluck, 2022, BMC Cardiovascular Disorders.

CMR quantitation of change in mitral regurgitation following transcatheter aortic valve replacement (TAVR): impact on left ventricular reverse remodeling and outcome

S. Plein, J. Greenwood, T. Fairbairn, 2018, The International Journal of Cardiovascular Imaging.

Association between operator volume and mortality in primary percutaneous coronary intervention

J. Greenwood, P. Baxter, D. Blackman, 2022, Open Heart.

Reply: Complete Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI: Is It Really What We Should Be Doing?

H. Swanton, Duolao Wang, M. Flather, 2015, Journal of the American College of Cardiology.

Intra-aortic Balloon Counterpulsation During High-Risk Percutaneous Coronary Intervention A Randomized Controlled Trial

R. Stables, D. Perera, S. Redwood, 2010 .

Expert Consensus on Sizing and Positioning of SAPIEN 3/Ultra in Bicuspid Aortic Valves

J. Kempfert, D. Blackman, J. Mascherbauer, 2021, Cardiology and Therapy.

Initial experience of a self‐expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry

M. Dalby, Richard A Anderson, M. Buch, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Severe aortic stenosis, critical coronary artery disease, and transfusion-dependent angiodysplasia - A management conundrum.

D. Blackman, C. Malkin, S. Rashid, 2016, Journal of cardiology cases.

Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.

I. Meredith, D. Blackman, G. Manoharan, 2015, JACC. Cardiovascular interventions.

Initial experience of a large, self‐expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters’ registry

M. Dalby, O. Demir, D. Hildick-Smith, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes.

M. Motwani, S. Plein, J. Greenwood, 2012, Journal of the American College of Cardiology.

NEED FOR PERMANENT PACEMAKER FOLLOWING IMPLANTATION OF THE REPOSITIONABLE LOTUS™ VALVE FOR THE TRANSCATHETER AORTIC VALVE REPLACEMENT IN 250 PATIENTS: RESULTS FROM THE REPRISE II TRIAL EXTENDED COHORT

J. Harnek, G. Rioufol, I. Meredith, 2015 .

Untreatable Severe Structural Degeneration of a Transcatheter Aortic Heart Valve

R. Lederman, N. Ali, D. Blackman, 2020, JACC. Case reports.

BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial.

D. Wood, T. Pilgrim, F. Vincent, 2022, American heart journal.

15 Clinical outcomes in patients treated with glycoprotein IIB/IIIA inhibitors during primary percutaneous coronary intervention according to arterial access site

J. Greenwood, P. Baxter, D. Blackman, 2018, Acute Coronary Syndromes.

Aortic Dissection and Injury

D. Blackman, V. Kushwaha, 2016 .

A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.

A. Brickman, A. Baumbach, P. Stella, 2015, European heart journal.

Percutaneous closure of an atrial septal defect in a patient with congenitally corrected transposition.

D. Blackman, J. Timperley, A. Mitchell, 2006, International journal of cardiology.

Use of the MANTA device to rescue failed pre-closure following transfemoral transcatheter aortic valve implantation.

N. Ali, D. Blackman, C. Malkin, 2019, Journal of cardiology cases.

Endothelium-derived nitric oxide contributes to the regulation of venous tone in humans.

J. Cockcroft, M. Frenneaux, J. Atherton, 2000, Circulation.

Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status

T. Moore, M. Frenneaux, J. Atherton, 2012, Heart and Vessels.

Stent fracture and collapse in a saphenous vein graft causing occlusive restenosis.

D. Blackman, P. Seidelin, M. Dorsch, 2006, The Journal of invasive cardiology.

Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.

R. Lange, R. Whitbourn, G. Rioufol, 2014, Journal of the American College of Cardiology.

Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study

H. Swanton, M. Flather, M. Dalby, 2016, Journal of the American Heart Association.

Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST‐Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design

J. Moon, J. Greenwood, A. Sirker, 2015, Clinical cardiology.

Trial Designs Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-Elevation Myocardial Infarction ( The MINIMISE STEMI Trial ) : Rationale and Study Design

J. Moon, A. Sirker, C. Ariti, 2015 .

The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR)

H. Swanton, M. Flather, M. Dalby, 2016 .

Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era

J. Greenwood, R. Cubbon, A. Aziz, 2012, Diabetes & vascular disease research.

Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door-to-balloon times in primary percutaneous coronary intervention.

J. Greenwood, A. F. Mackintosh, D. Blackman, 2008, American heart journal.

Revascularisation for acute coronary syndromes in older people

John D Ferguson, D. Blackman, A. Banning, 2003 .

Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service.

J. Greenwood, A. Crean, D. Blackman, 2010, American heart journal.

Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design.

H. Swanton, M. Flather, M. Dalby, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress

S. Jackson, M. Frenneaux, J. Morris-Thurgood, 2002, European journal of heart failure.

A risk scoring system to predict coronary stent thrombosis

A. Baumbach, R. Stables, A. Zaman, 2017, Current medical research and opinion.

L. Sharples, S. Plein, J. Greenwood, 2016, American heart journal.

Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial

K. Abrams, J. Greenwood, V. Kunadian, 2016, European heart journal.

Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy.

S. Jackson, M. Lewis, M. Frenneaux, 2000, Journal of the American College of Cardiology.

Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study

V. Falk, P. Wenaweser, H. Ince, 2017, European heart journal.

Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status

S. Plein, J. Greenwood, G. Worthy, 2011, Heart.

Silent cerebral infarction and cognitive function following TAVI: an observational two-centre UK comparison of the first-generation CoreValve and second-generation Lotus valve

S. Plein, J. Greenwood, D. Blackman, 2019, BMJ Open.

Percutaneous coronary intervention in octogenarians with refractory angina

K. Channon, D. Blackman, A. Banning, 2002, Heart.

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study

V. Falk, P. Wenaweser, I. Meredith, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.

V. Falk, P. Wenaweser, H. Ince, 2019, JACC. Cardiovascular interventions.

Use of a Repositionable and FullyRetrievable Aortic Valve in RoutineClinical Practice

V. Falk, P. Wenaweser, H. Ince, 2022 .

A Longitudinal Echocardiographic Analysis of Patients Treated Using the Repositionable and Fully Retrievable Lotus Valve: A Sub-Analysis of the RESPOND Study

V. Falk, I. Meredith, Chun-Chin Chang, 2020 .

Measurement of Diastolic Blood Pressure in Obstetrical Research

G. Lip, D. Beevers, D. Blackman, 1996 .

Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study

M. Motwani, S. Plein, J. Greenwood, 2012, Heart.

041 Serial change in health related quality of life over 1 year following transcatheter aortic valve implantation: predictors of health outcomes

M. Motwani, S. Plein, T. Fairbairn, 2012, Heart.

129 Prosthetic valve endocarditis following transcatheter aortic valve implantation – experience from a UK centre

N. Ali, D. Blackman, J. Sandoe, 2019, Valve Disease/Pericardial Disease/Cardiomyopathy.

Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality

S. Plein, J. Greenwood, A. Mcdiarmid, 2017, Journal of Cardiovascular Magnetic Resonance.

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.

I. Porto, K. Channon, D. Blackman, 2004, The American journal of cardiology.

RESULTS OF THE REPOSITIONABLE PERCUTANEOUS REPLACEMENT OF STENOTIC AORTIC VALVE WITH THE LOTUS™ VALVE SYSTEM – EVALUATION OF SAFETY AND PERFORMANCE (REPRISE II) STUDY: 3-MONTH OUTCOMES IN HIGH-RISK SURGICAL PATIENTS

R. Whitbourn, G. Rioufol, I. Meredith, 2014 .

1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

R. Lange, R. Whitbourn, G. Rioufol, 2016, JACC. Cardiovascular interventions.

Long‐term durability of self‐expanding and balloon‐expandable transcatheter aortic valve prostheses: UK TAVI registry

N. Ali, D. Hildick-Smith, M. Buch, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Morphometric and traditional frailty assessment in transcatheter aortic valve implantation.

D. Blackman, M. Drozd, D. Scott, 2020, Journal of cardiovascular medicine.

TCT-39 Three-Year Outcomes with the Fully Repositionable and Retrievable Lotus™ Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

R. Whitbourn, G. Rioufol, I. Meredith, 2014 .

Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation.

S. Plein, J. Greenwood, T. Fairbairn, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial.

A. Baumbach, R. Stables, P. Ludman, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

C. Terkelsen, J. Mehilli, B. Iung, 2022, European heart journal. Quality of care & clinical outcomes.

TAVI in younger patients with bicuspid aortic stenosis: pros and cons.

M. Borger, D. Blackman, Noman Ali, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

TCT-98 Clinical Outcomes at 1 Year with a Repositionable Self-Expanding Transcatheter Aortic Valve

I. Meredith, D. Blackman, G. Manoharan, 2015 .

LBT-1 Transcatheter Aortic Valve Replacement Using the Lotus Valve with Depth Guard: First Report from the RESPOND Extension Study

D. Hildick-Smith, D. Blackman, A. Witkowski, 2017 .

‘Valve for Life’: tackling the deficit in transcatheter treatment of heart valve disease in the UK

N. Curzen, N. Ali, P. Ludman, 2021, Open Heart.